TIAA CREF INVESTMENT MANAGEMENT LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,392,000
-61.2%
238,398
-37.7%
0.00%
-66.7%
Q4 2018$3,584,000
-79.8%
382,463
-63.3%
0.00%
-50.0%
Q3 2018$17,748,000
+83.0%
1,042,116
+82.5%
0.01%
-14.3%
Q2 2018$9,701,000
+175.5%
570,999
+117.6%
0.01%
+250.0%
Q1 2018$3,521,000
+359.1%
262,388
+228.4%
0.00%
+100.0%
Q4 2017$767,000
-23.0%
79,898
-11.9%
0.00%0.0%
Q3 2017$996,000
+6.4%
90,677
-12.3%
0.00%0.0%
Q2 2017$936,000
+5.4%
103,437
+49.6%
0.00%0.0%
Q1 2017$888,000
+33.9%
69,122
-2.0%
0.00%
Q4 2016$663,000
-12.6%
70,557
-9.6%
0.00%
Q3 2016$759,000
+48.2%
78,027
+2.2%
0.00%
Q2 2016$512,000
-21.2%
76,318
+4.7%
0.00%
Q1 2016$650,000
-35.6%
72,892
-4.4%
0.00%
-100.0%
Q4 2015$1,010,000
+25.9%
76,2080.0%0.00%0.0%
Q3 2015$802,000
-61.7%
76,208
-0.9%
0.00%0.0%
Q2 2015$2,092,000
+32.1%
76,871
+48.5%
0.00%0.0%
Q1 2015$1,584,000
-12.0%
51,750
+7.6%
0.00%0.0%
Q4 2014$1,800,000
+10.4%
48,089
+3.1%
0.00%0.0%
Q3 2014$1,630,000
-26.2%
46,649
-1.6%
0.00%
-50.0%
Q2 2014$2,208,000
+140.3%
47,431
+59.4%
0.00%
+100.0%
Q1 2014$919,000
+95.1%
29,759
+45.0%
0.00%
Q4 2013$471,00020,5290.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders